Turinabol (4‑Chlorodehydromethyltestosterone)
Oral anabolic steroid that was the main agent of the GDR state doping program; banned in sport and detectable for a long time.


The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
What is Turinabol (4-Chlorodehydromethyltestosterone)?
Turinabol (4-Chlorodehydromethyltestosterone, CDMT) is an orally taken, synthetic anabolic steroid, a compound that imitates the effect of testosterone and builds muscle. It was developed in East Germany and sold as a prescription medicine, but its production was later discontinued. It became notorious as the main agent of the GDR's state doping program: more than ten thousand athletes received it, many of them without knowing.
It strains the liver moderately, and a rise in liver enzymes is common. It shuts down the body's own testosterone production, worsens cholesterol values, raises blood pressure, and can cause mood disorders, aggression and dependence. According to later archive documents, athletes suffered liver damage and heart muscle disease, women suffered irreversible masculinization, and children of doped mothers were born with malformations. It must not be used in pregnancy. It is banned in competitive sport all year round and can be detected in urine for up to a year and a half; in Hungary and Poland it is illegal without a prescription.
Mechanism
AR agonist, 17α-methyl-4-chloro-Δ1-T, NOT aromatized
Anabolic:Androgenic
53:6
Half-life
16 hours (oral)
Onset
2-3 h (oral)
Legal status
Jenapharm Rx (DE) discontinued 1994; UGL today. Schedule III.
Turinabol is often overshadowed by Anadrol or Dianabol, but anecdotal reports value it precisely for being less flashy. Users commonly describe progress as steady, efficient, and deceptively productive – changes accrue slowly rather than exploding. Strength tends to rise without massive bodyweight jumps, which is central to its reputation. It is also associated with strong performance carryover: not just looking different, but moving better, recovering better, and sustaining output. Some users view it closer to a 'lean-tissue optimizer' than a classic mass drug. Because it does not aromatize, the visual is typically harder and drier, though without the dramatic fullness of more glycogen-heavy compounds. Despite a milder profile, Turinabol can still negatively affect lipids, liver enzymes, blood pressure, and natural testosterone production – these are often underestimated because the compound feels smoother. As a 17α-alkylated oral, hepatic stress remains relevant; 'mild' should not be confused with harmless.
⚠ Not clinical evidence – based on user accounts.
Data console
Lab data
Franke WW, Berendonk B. . Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem. 1997;43(7):1262-79..
Sobolevsky T, Rodchenkov G. . Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine. J Steroid Biochem Mol Biol. 2012;128(3-5):121-7..
Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. . Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341-75..
Hartgens F, Kuipers H. . Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-554..
Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. . Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104(12):1966-78..
Safety
Side effects, stop signs, contraindications
Side effects · 7
- HPTA suppression: endogenous testosterone production shuts down (LH/FSH suppression), testicular atrophy, reduced libido and fertility; prolonged hypogonadism without PCT.
- Adverse lipid changes: moderate-to-marked HDL drop (15-25%) and LDL rise, pronounced with oral 17alpha-alkylated AAS; long-term atherosclerosis risk.
- Hepatotoxicity (oral 17alpha-methyl): ALT/AST elevation 2-3x over 6+ week cycles; clinically milder than Dianabol/Anadrol (4-chloro protection), but liver stress is real, with rare cholestasis and peliosis hepatis.
- Virilization in women: despite the low androgenic ratio, >10 mg/day and longer exposure can cause IRREVERSIBLE voice deepening, clitoral enlargement, hirsutism (documented GDR case: Heidi/Andreas Krieger).
- Elevated blood pressure: hypertension is common during AAS cycles; combined with HDL decline and hematocrit changes it increases cardiovascular load.
- Psychiatric effects: irritability, aggression, mood swings on cycle, plus depression and low libido during cessation/PCT; AAS dependence can develop.
- Androgenic skin effects: acne and oily skin can occur; scalp hair-loss risk is low, however, since Turinabol is not a 5alpha-reductase substrate (no DHT conversion).
Contraindications · 7
- Pregnancy and breastfeeding: absolutely contraindicated due to virilization and risk of fetal developmental abnormalities (the GDR program documented neonatal abnormalities in children of doped mothers).
- Any liver disease or elevated liver enzymes: the 17alpha-methyl group adds hepatic stress, so it must not be used with pre-existing liver impairment.
- Cardiovascular disease, hypertension or adverse lipid profile: HDL decline and raised blood pressure worsen existing cardiovascular risk.
- Hormone-sensitive tumors (prostate or breast carcinoma): contraindicated as an androgen-receptor agonist.
- WADA-tested athletes: extra-long detection window (12-18 months in urine due to Sobolevsky-Rodchenkov 2012 long-term metabolites); to be avoided at any career stage.
- Psychiatric predisposition (depression, bipolar disorder, aggression-control problems): mood side effects and post-cycle depression can exacerbate it.
- Adolescents and growing youths: AAS can cause premature epiphyseal closure and irreversible developmental effects.
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government
Franke WW, Berendonk B.
Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine
Sobolevsky T, Rodchenkov G.
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement
Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S.
Effects of androgenic-anabolic steroids in athletes
Hartgens F, Kuipers H.
Anabolic-androgenic steroid dependence: an emerging disorder
Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr.
Telegram
Have a question about Turinabol (4‑Chlorodehydromethyltestosterone)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.